1,367 results on '"Muller, William J."'
Search Results
2. Osteopontin is a therapeutic target that drives breast cancer recurrence
3. Targeting fatty acid oxidation enhances response to HER2-targeted therapy
4. Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation
5. Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
6. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient
7. Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
8. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer
9. CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis
10. Return to School for Pediatric Solid Organ Transplant Recipients in the United States During the Coronavirus Disease 2019 Pandemic: Expert Opinion on Key Considerations and Best Practices
11. Epstein-Barr Virus (Mononucleosis and Lymphoproliferative Disorders)
12. Contributors
13. Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer
14. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels
15. ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
16. Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency
17. Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control
18. Live virus vaccination following pediatric liver transplantation: Outcomes from two academic children’s hospitals
19. Emergence of β1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment
20. Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies
21. An ErbB2 splice variant lacking exon 16 drives lung carcinoma
22. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
23. Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients.
24. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020).
25. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).
26. A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials.
27. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity
28. A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials
29. The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
30. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy
31. Vaccines for COVID-19 and RSV: An update: William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children and what is on the horizon for a potential RSV vaccine
32. Herpes simplex and varicella-zoster viruses
33. Contributors
34. Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment
35. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
36. 1699. Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients
37. 1934. Nirsevimab is Associated with Higher and More Sustained RSV Neutralizing Antibody Responses Compared with Standard of Care Palivizumab: Observations from a 2:1 Randomized, Phase 2/3 Trial in Medically Vulnerable Children (MEDLEY)
38. Supplementary Data Legends from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
39. Supplementary Figures from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
40. Data from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
41. In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches
42. Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis
43. An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis
44. Clinical and in vitro Evaluation of Cidofovir for Treatment of Adenovirus Infection in Pediatric Hematopoietic Stem Cell Transplant Recipients
45. Germ-Line Expression of an Oncogenic erbB2 Allele Confers Resistance to erbB2-Induced Mammary Tumorigenesis
46. The Shc Adaptor Protein Is Critical for VEGF Induction by Met/HGF and ErbB2 Receptors and for Early Onset of Tumor Angiogenesis
47. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model
48. Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network
49. Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways
50. HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.